Site Search

... that they are generally larger, more complex molecules. Biologics are usually administered via injection or infusion. Most biologics in cancer care are given under the close supervision of a medical professional.   Q. What is a biosimilar? Answer: A biosimilar is a biologic product ... strength as its reference product.  Q. Why does the biosimilar pathway exist? Answer: Biologics have become an increasingly important part of health care. With the increasing attention to the costs of drugs, it became apparent that there was a need to create competition and choice that ... Your healthcare provider may have various reasons for selecting a branded biologic or biosimilar, including experience with the product, your health plan’s formulary (permitted drugs), patient preference, cost consciousness, or some combination of these factors. You should ask your ...

... Elizabeth J. Cathcart-Rake, M.D., Mayo Clinic, Jasmine Gowarty, M.D., Texas Oncology, Jessica Gilbertson, National Council for Urban Indian Health, Keeshia Jones, Sisters Network, Inc. & ABCD, Sunaina Mathur, Cancer Stompers, Flecia Brown, ACS CAN Georgia Lead Volunteer, Ashton ... is Being Left Behind – Why Aren’t They Included in Clinical Trials?” to discuss the Black community’s unique challenges to cancer care.  Watch the recording Download the Fireside Chat Program   Clinical Trials: Why Black Community Participation Matters Dr. Sara Horton, ... Horton demystifies common misconceptions about clinical trials and how increasing Black patients enrollment in trials improves the standard of care for everyone.   BVC In Action ...

... provide you with all of the resources you need to feel prepared and confident going into the event.  We are advocating for greater access to health care coverage, including closing the coverage gap, so other patients can survive cancer too. Date:   Tuesday, February 4th Time:    8:00 AM to ...

... not accomplish the critical cancer advocacy work that we do without the generosity of our sponsors.   What is Biomarker Testing? In cancer care, biomarkers are often used to help determine the best treatment for a patient . A “ biomarker ” is a sign of a normal biological process, ... that have been excluded, including communities of color, individuals with lower socioeconomic status, rural communities, and those receiving care in non-academic medical centers are less likely to receive biomarker testing. Improving coverage for and access to biomarker testing across insurance types is key to reducing health disparities. Without action to expand coverage and access to biomarker testing, advances in precision medicine could increase existing ...